Adaptive dose‐response studies to establish proof‐of‐concept in learning‐phase clinical trials
From MaRDI portal
Publication:6068332
DOI10.1002/BIMJ.202100044zbMath1523.62162arXiv2102.10434OpenAlexW3202019112MaRDI QIDQ6068332
Unnamed Author, Michael P. McDermott
Publication date: 15 December 2023
Published in: Biometrical Journal (Search for Journal in Brave)
Full work available at URL: https://arxiv.org/abs/2102.10434
adaptive designsproof-of-conceptconditional rejection probability principlegeneralized multiple contrast testsMCP-Mod
Cites Work
- Unnamed Item
- Response-adaptive dose-finding under model uncertainty
- Combining dependent \(P\)-values.
- Group Sequential and Confirmatory Adaptive Designs in Clinical Trials
- Adaptive dose-finding: Proof of concept with type I error control
- Adaptive Group Sequential Designs for Clinical Trials: Combining the Advantages of Adaptive and of Classical Group Sequential Approaches
- Recursive Combination Tests
- Evaluation of Experiments with Adaptive Interim Analyses
- Probabilistic Foundation of Confirmatory Adaptive Designs
- Conditional Rejection Probabilities of Student'st-test and Design Adaptations
- Combining Multiple Comparisons and Modeling Techniques in Dose‐Response Studies
This page was built for publication: Adaptive dose‐response studies to establish proof‐of‐concept in learning‐phase clinical trials